↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Book
  • The PIV Blog
  • PIV Data
    • Get Access
Home→Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

Home › Forums › Non-PIV Patent Cases and Non-PIV Inter Partes Reviews

  • This forum has 1 topic, and was last updated 17 years, 5 months ago by gregoryglass.
Viewing topic 1 (of 1 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • The Non-PIV Cases and IPR’s

      Started by: gregoryglass

    • 1
    • 1
    • 17 years, 5 months ago

      gregoryglass

  •  

Viewing topic 1 (of 1 total)
  • You must be logged in to create new topics.
Log In

Login

Log In

Latest updates

Minocin®(minocycline) Injection
Annual Sales
Company MELINTA
Date of First Filing October 16, 2020

Paragraph IV Applicant: Nexus
Case Name: MELINTA THERAPEUTICS LLC et al v. NEXUS PHARMACEUTICALS
Court/Case #: New Jersey District Court (njdc) 2:2021cv11198
Date Filed: 5/13/21
Judge: Martinotti
Product Strength: 100…Read more

Profile picture of parryashford 1 day, 3 hours ago

Parsabiv®(etelcalcetide) Injection
Annual Sales $630M
Company AMGEN
Date of First Filing February 8, 2021

Paragraph IV Applicant: Aurobindo
Case Name: AMGEN INC et al v. AUROBINDO PHARMA LIMITED et al
Court/Case #: Delaware District Court (dedc) 1:2021cv00662
Date Filed: 5/6/21
Judge:
Product Strength: 2.5mg/0.5mL, 5mg/mL, and…Read more

Profile picture of parryashford 3 days, 22 hours ago

The Paragraph Four Report®
Paragraph IV Activity for April 2021

New Certifications as reported by FDA on April 6 and 20, 2021

1. Parsabiv®(etelcalcetide) Injection 2.5mg/0.5mL, 5mg/mL, and 10mg/2mL on 2/8/2021
2. Tiglutik®(riluzole) Oral Suspension 50mg/10mL on 3/12/2021
3. Lexette®(halobetasol) Topical Foam 0.05% on 1/2…Read more

Profile picture of parryashford 2 weeks ago
The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2021
↑